Regulatory News In Brief

08 Apr 2013

FDA issues guidance documents on PMA and 510(k) user fees and refunds. Agency issues proposed order for three pre-amendment devices. More regulatory news.

FDA is inviting stakeholders to discuss the development of an international consortium of cardiovascular registries at a public meeting April 22 in Silver Spring, Md. The agency says it plans a pilot phase for the project focused on “developing relationships and analysis strategies for transcatheter cardiac valve registries.” The initial efforts focused on linking transcatheter valve registries “would be expanded to additional cardiovascular devices in the future,” FDA says.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Medtech Seeks Inclusion In EU’s Groundbreaking Life Sciences Strategy

29 Apr 2025

• By Amanda Maxwell

As the EU Life Sciences Strategy aims to drive innovation, the medtech sector is pushing for a pivotal role in a mission intended to embrace green and digital transitions, address regulatory obstacles and reduce dependency on external sources.

‘The FDA Will Be Looking For Avenues To Regulate Laboratory Developed Tests’

24 Apr 2025

• By Natasha Barrow

The FDA's final LDT ruling was struck down in federal court last month. For now, diagnostic companies can commercialize under CLIA regulations or apply for FDA approval. McDermott and Tribun Health have shared insights on the risks, pros and cons of both regulatory routes.